Central Idea On May 25, the USFDA granted approval for clinical trials of Neuralink’s implantable Brain-Computer Interface (BCI), developed by tech mogul Elon Musk’s neurotech startup. While Neuralink’s ambitions are revolutionary, promising to treat brain disorders and fuse human consciousness with AI, there are significant concerns regarding the safety, viability, and transparency of the technology. … Continue reading Implantable Brain-Computer Interface